CRO · Private company
FGK Clinical Research GmbH
Track this companyFree. Adds FGK Clinical Research GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 26, 2024ClinicalTrials.gov NCT06489028 · fetched Nov 12, 2026
- Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCDPHASE1_PHASE2 · UNKNOWN · started Jul 4, 2019ClinicalTrials.gov NCT03549299 · fetched Nov 12, 2026
- Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis BullosaPHASE1_PHASE2 · COMPLETED · started Feb 16, 2019ClinicalTrials.gov NCT03529877 · fetched Nov 12, 2026
- A Phase 2 Study of Cyclo-Z in Subjects With Type 2 DiabetesPHASE2 · COMPLETED · started Jun 18, 2018ClinicalTrials.gov NCT03560271 · fetched Nov 12, 2026
- A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.NA · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01961687 · fetched Nov 12, 2026
- Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal DiseasePHASE1 · COMPLETED · started May 23, 2013ClinicalTrials.gov NCT01840956 · fetched Nov 12, 2026